Mathieu Robain

1.7k total citations
33 papers, 266 citations indexed

About

Mathieu Robain is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Mathieu Robain has authored 33 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Mathieu Robain's work include Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (9 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Mathieu Robain is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (9 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Mathieu Robain collaborates with scholars based in France, Canada and Germany. Mathieu Robain's co-authors include Laurence Meyer, Bernard Asselain, Jean‐Yves Pierga, Élisabeth Dussaix, Fabien Reyal, Roman Rouzier, Dominique Salmon‐Céron, Florence Lerebours, Denise Stevens and Nicolas Carré and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mathieu Robain

31 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Robain France 8 106 82 55 43 42 33 266
Weidong Zhang China 10 103 1.0× 94 1.1× 40 0.7× 12 0.3× 55 1.3× 24 429
Paulo Henrique Lima Brazil 5 104 1.0× 155 1.9× 21 0.4× 25 0.6× 15 0.4× 9 285
Mario Tamburini Italy 8 189 1.8× 113 1.4× 30 0.5× 53 1.2× 11 0.3× 11 360
S M Devine United States 9 119 1.1× 99 1.2× 29 0.5× 6 0.1× 66 1.6× 12 517
Annie Darilay United States 8 130 1.2× 105 1.3× 23 0.4× 13 0.3× 59 1.4× 12 317
Johannes Mejer Denmark 10 179 1.7× 82 1.0× 13 0.2× 29 0.7× 50 1.2× 29 397
J Maral France 10 101 1.0× 58 0.7× 29 0.5× 105 2.4× 61 1.5× 29 344
Tara M. Allos United States 10 78 0.7× 84 1.0× 13 0.2× 57 1.3× 103 2.5× 12 434
Xinan Wan Australia 8 249 2.3× 123 1.5× 13 0.2× 44 1.0× 14 0.3× 12 434
Asmae Gassa Germany 10 65 0.6× 101 1.2× 79 1.4× 5 0.1× 51 1.2× 16 306

Countries citing papers authored by Mathieu Robain

Since Specialization
Citations

This map shows the geographic impact of Mathieu Robain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Robain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Robain more than expected).

Fields of papers citing papers by Mathieu Robain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Robain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Robain. The network helps show where Mathieu Robain may publish in the future.

Co-authorship network of co-authors of Mathieu Robain

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Robain. A scholar is included among the top collaborators of Mathieu Robain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Robain. Mathieu Robain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérol, David, et al.. (2023). Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort. JNCI Journal of the National Cancer Institute. 115(8). 971–980. 5 indexed citations
2.
Ezzalfani, Monia, Raphaël Porcher, Alexia Savignoni, et al.. (2021). Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project. PLoS ONE. 16(9). e0255017–e0255017. 2 indexed citations
3.
Girard, Nicolas, M. Pérol, Clarisse Audigier-Valette, et al.. (2021). Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort. Lung Cancer. 162. 119–127. 5 indexed citations
4.
Delaloge, Suzette, Marc Debled, William Jacot, et al.. (2020). 279MO Divergent evolution of overall survival across metastatic breast cancer (MBC) subtypes in the nationwide ESME real life cohort 2008-2016. Annals of Oncology. 31. S352–S353. 3 indexed citations
5.
6.
Dièras, Véronique, Frédérique Berger, Philippe Beuzeboc, et al.. (2017). First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study. Anticancer Research. 37(3). 1403–1408. 6 indexed citations
7.
Berdaï, Driss, Karine Szwarcensztein, Anne d’Andon, et al.. (2017). Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases. Therapies. 73(1). 13–24. 5 indexed citations
8.
Berdaï, Driss, Karine Szwarcensztein, Anne d’Andon, et al.. (2017). Demandes d’études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données. Therapies. 73(1). 1–12. 2 indexed citations
9.
Sablin, Marie‐Paule, Delphine Loirat, Thomas Bachelot, et al.. (2017). Triple-NOTE (Triple Negative Outcome in ESME): Large recent real-world prognostic data on triple negative metastatic breast cancers (mTNBC).. Journal of Clinical Oncology. 35(15_suppl). e12592–e12592. 1 indexed citations
10.
Stevens, Denise, Jean‐Yves Pierga, Florence Lerebours, et al.. (2015). Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population. PLoS ONE. 10(7). e0132853–e0132853. 44 indexed citations
11.
Héquet, Delphine, et al.. (2015). Age impact on human papillomavirus vaccination in France in 2014: A study from the National Health Insurance Database. Bulletin du Cancer. 102(11). 892–897. 3 indexed citations
12.
Salmon, Dominique, Mathieu Robain, Jürgen K. Rockstroh, & Yves Benhamou. (2005). Therapeutic management of hepatitis and HIV infection in co-infected patients: Results of a survey performed before the 2005 Consensus Conference. Journal of Hepatology. 44(1 Suppl). S2–S5. 14 indexed citations
13.
Roque-Afonso, A.M., et al.. (2002). Influence of CD4 Cell Counts on the Genetic Heterogeneity of Hepatitis C Virus in Patients Coinfected with Human Immunodeficiency Virus. The Journal of Infectious Diseases. 185(6). 728–733. 23 indexed citations
14.
Robain, Mathieu, Faroudy Boufassa, Jean‐Baptiste Hubert, et al.. (2001). Cytomegalovirus seroconversion as a cofactor for progression to AIDS. AIDS. 15(2). 251–256. 19 indexed citations
15.
Robain, Mathieu, Frédéric Davi, Richard Garand, et al.. (2001). A Multicentric Study of 41 Cases of B-Prolymphocytic Leukemia: Two Evolutive Forms: The Groupe Français d'Hématologie Cellulaire. Leukemia & lymphoma. 42(5). 981–987. 25 indexed citations
16.
Pierga, Jean‐Yves, Mathieu Robain, M Jouve, et al.. (2001). Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients. Annals of Oncology. 12(2). 231–238. 29 indexed citations
17.
Robain, Mathieu, et al.. (2000). Is cytomegalovirus infection a co-factor in HIV-1 disease progression?. Epidemiology and Infection. 125(2). 415–420. 5 indexed citations
18.
Robain, Mathieu, Jean‐Yves Pierga, M Jouve, et al.. (2000). Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer. European Journal of Cancer. 36(18). 2301–2312. 16 indexed citations
19.
Robain, Mathieu, Nicolas Carré, Élisabeth Dussaix, Dominique Salmon‐Céron, & Laurence Meyer. (1998). Incidence and Sexual Risk Factors of Cytomegalovirus Seroconversion in HIV-Infected Subjects. Sexually Transmitted Diseases. 25(9). 476–480. 22 indexed citations
20.
Carré, Nicolas, Mathieu Robain, Élisabeth Dussaix, Dominique Salmon‐Céron, & Laurence Meyer. (1997). Sexual Factors Associated With Cytomegalovirus Seropositivity in Human Immunodeficiency Virus-Infected Men. Sexually Transmitted Diseases. 24(10). 582–586. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weidong Zhang Breakdown of academic impact, for papers by Paulo Henrique Lima Breakdown of academic impact, for papers by Mario Tamburini Breakdown of academic impact, for papers by S M Devine Breakdown of academic impact, for papers by Annie Darilay Breakdown of academic impact, for papers by Johannes Mejer Breakdown of academic impact, for papers by J Maral Breakdown of academic impact, for papers by Tara M. Allos Breakdown of academic impact, for papers by Xinan Wan Breakdown of academic impact, for papers by Asmae Gassa
Rankless by CCL
2026